Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Free Cash Flow Generation Index
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Free Cash Flow Generation Index of -0.83x as of September 2025. Free cash flow of CN¥-32.78 Million represents -1% of operating cash flow (CN¥39.68 Million). Explore 002653 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2008–2025)
Historical FCF Generation Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Xizang Haisco Pharmaceutical Group Co Lt cash conversion from operations.
Annual Free Cash Flow Generation for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year Free Cash Flow Generation Index for Xizang Haisco Pharmaceutical Group Co Ltd. Check 002653 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥454.03 Million | CN¥786.00 Million | CN¥331.98 Million | ▲ +18255.3% |
| 2024 | 0.00x | CN¥1.39 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -97.6% |
| 2023 | 0.13x | CN¥58.57 Million | CN¥449.58 Million | CN¥391.01 Million | ▲ +102.0% |
| 2022 | -6.41x | CN¥-605.62 Million | CN¥94.55 Million | CN¥700.17 Million | ▲ +65.6% |
| 2021 | -18.63x | CN¥-667.14 Million | CN¥35.80 Million | CN¥702.94 Million | ▼ -871.5% |
| 2020 | -1.92x | CN¥-395.51 Million | CN¥206.21 Million | CN¥601.72 Million | ▼ -907.3% |
| 2019 | 0.24x | CN¥181.58 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -6.9% |
| 2018 | 0.26x | CN¥120.62 Million | CN¥472.61 Million | CN¥351.98 Million | ▲ +7008.0% |
| 2017 | 0.00x | CN¥-1.45 Million | CN¥391.81 Million | CN¥393.26 Million | ▼ -100.7% |
| 2016 | 0.53x | CN¥217.87 Million | CN¥409.20 Million | CN¥208.24 Million | ▲ +48.0% |
| 2015 | 0.36x | CN¥159.35 Million | CN¥443.03 Million | CN¥283.68 Million | ▼ -32.5% |
| 2014 | 0.53x | CN¥267.71 Million | CN¥502.57 Million | CN¥234.86 Million | ▼ -25.1% |
| 2013 | 0.71x | CN¥404.43 Million | CN¥568.41 Million | CN¥163.98 Million | ▼ -2.6% |
| 2012 | 0.73x | CN¥339.45 Million | CN¥464.75 Million | CN¥125.30 Million | ▲ +33.1% |
| 2011 | 0.55x | CN¥143.07 Million | CN¥260.79 Million | CN¥117.72 Million | ▼ -29.6% |
| 2010 | 0.78x | CN¥286.43 Million | CN¥367.38 Million | CN¥80.95 Million | ▼ -16.6% |
| 2009 | 0.93x | CN¥344.21 Million | CN¥368.21 Million | CN¥24.01 Million | ▲ +54.7% |
| 2008 | 0.60x | CN¥57.07 Million | CN¥94.45 Million | CN¥37.38 Million | — |